Format

Send to:

Choose Destination

Similar articles for PubMed (Select 24561477)

See comment in PubMed Commons below
Toxins (Basel). 2014 Feb 20;6(2):650-64. doi: 10.3390/toxins6020650.

Breakdown of phosphatidylserine asymmetry following treatment of erythrocytes with lumefantrine.

Author information

  • 1Department of Physiology, University of Tuebingen, Gmelinstr. 5, D-72076 Tübingen, Germany. kossai.z@gmail.com.
  • 2Department of Physiology, University of Tuebingen, Gmelinstr. 5, D-72076 Tübingen, Germany. samosamosamo@hotmail.de.
  • 3Department of Physiology, University of Tuebingen, Gmelinstr. 5, D-72076 Tübingen, Germany. gregor.oswald@gmx.de.
  • 4Department of Physiology, University of Tuebingen, Gmelinstr. 5, D-72076 Tübingen, Germany. Myriam.fezai@gmail.com.
  • 5Department of Physiology, University of Tuebingen, Gmelinstr. 5, D-72076 Tübingen, Germany. dr.magd81@hotmail.com.
  • 6Department of Physiology, University of Tuebingen, Gmelinstr. 5, D-72076 Tübingen, Germany. florian.lang@uni-tuebingen.de.

Abstract

BACKGROUND:

Lumefantrine, a commonly used antimalarial drug, inhibits hemozoin formation in parasites. Several other antimalarial substances counteract parasitemia by triggering suicidal death or eryptosis of infected erythrocytes. Eryptosis is characterized by cell shrinkage and cell membrane scrambling leading to phosphatidylserine-exposure at the erythrocyte surface. Signaling involved in eryptosis include increase of cytosolic Ca2+-activity ([Ca2+]i), formation of ceramide, oxidative stress and/or activation of p38 kinase, protein kinase C (PKC), or caspases. The present study explored, whether lumefantrine stimulates eryptosis.

METHODS:

Cell volume has been estimated from forward scatter, phosphatidylserine-exposure from annexin V binding, [Ca2+]i from Fluo3-fluorescence, reactive oxygen species from 2',7'-dichlorodihydrofluorescein-diacetate fluorescence, content of reduced glutathione (GSH) from mercury orange fluorescence, and ceramide abundance from binding of fluorescent antibodies in flow cytometry.

RESULTS:

A 48 h exposure to lumefantrine (3 µg/mL) was followed by a significant increase of annexin-V-binding without significantly altering forward scatter, [Ca2+]i, ROS formation, reduced GSH, or ceramide abundance. The annexin-V-binding following lumefantrine treatment was not significantly modified by p38 kinase inhibitors SB203580 (2 μM) and p38 Inh III (1 μM), PKC inhibitor staurosporine (1 µM) or pancaspase inhibitor zVAD (1 or 10 µM).

CONCLUSIONS:

Lumefantrine triggers cell membrane scrambling, an effect independent from entry of extracellular Ca2+, ceramide formation, ROS formation, glutathione content, p38 kinase, PKC or caspases.

PMID:
24561477
[PubMed - indexed for MEDLINE]
PMCID:
PMC3942757
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
    Loading ...
    Write to the Help Desk